-transparent.png){kind=logo}
Methylphosphonic dichloride was used to prepare protected deoxyribonucleoside 3'-methylphosphonate beta-cyanoethyl esters, d-[(MeO)2Tr]NpCNEt, and protected oligonucleoside methylphosphonates in solution. Reaction of d-[(MeO)2Tr]N with methylphosphonic dichloride gives d-[(MeO)2Tr]NpCl. The phosphonylation and subsequent esterification or condensation reactions are each complete within 60 min. The products are readily purified by "flash chromatography" on silica gel columns. d-[(MeO)2Tr]NpCl, or its tetrazole derivative, d-[(MeO)2Tr]Nptet, were tested as intermediates for the synthesis of oligothymidine methylphosphonates on a silica gel polymer support. The average yield per coupling step was 76% and did not increase with addition of more d-[(MeO)2Tr]TpCl. The formation of (5'-5') linked thymidine dimers indicated that the thymidine monomers are clustered closely together on the support. When N is ibuG, the yield for the coupling step on the support is very low. This may be due to steric hindrance of the 3'-phosphonate group by the N-2 isobutryl protecting group.
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
April 1991,
Bio/technology (Nature Publishing Company),
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
July 2000,
Biochemistry,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
January 1996,
Antisense & nucleic acid drug development,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
September 1999,
Nucleosides & nucleotides,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
January 1990,
Bioconjugate chemistry,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
August 1994,
Biochemistry,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
January 1989,
Cancer communications,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
May 1990,
Anti-cancer drug design,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
December 1988,
Biochemistry,
P S Miller, and
C H Agris, and
M Blandin, and
A Murakami, and
P M Reddy, and
S A Spitz, and
P O Ts'o
August 2018,
Talanta,
